biote
Open
$2.21
Prev. Close
$2.21
High
$2.23
Low
$2.21
Market Snapshot
$64.77M
-44.1
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 223 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
emptyResult
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 223 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Recently from Cashu
Biote's Earnings Call: Key Insights on Growth and Hormone Optimization Solutions Ahead
Biote's Quarterly Earnings Call: A Crucial Moment for Hormone Optimization Solutions As Biote prepares to release its quarterly earnings on March 11, 2026, the company stands at a pivotal crossroads i…
Biote Earnings Call: Revenue Growth and Future Strategies in Hormone Optimization Market
Biote's Earnings Announcement: A Focus on Hormone Optimization and Market Strategy Biote, a leading player in hormone optimization solutions, prepares for its quarterly earnings announcement on March…
Biote's Earnings Report: Insights on Future Growth in Hormone Optimization Solutions
Biote's Future Growth in Hormone Optimization Solutions Biote is set to unveil its quarterly earnings on March 11, 2026, and analysts are keenly observing the company’s financial trajectory, particula…
Biote's Strategic Expansion Drives Robust Growth Amidst Economic Challenges
Biote Sets Precedent with Robust Growth and Strategic Expansion In the competitive landscape of biotechnology, Company XYZ emerges as a key player set to report its earnings, with analysts projecting…